Health Insurance Portability and Accountability Act (HIPAA): Must there be a trade-off between privacy and quality of health care, or can we advance both?

Circulation

Volumn 108, Issue 8, 2003, Pages 915-918

  Califf, Robert M ^a   Muhlbaier, Lawrence H ^b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE QUALITY; HEALTH INSURANCE; LAW; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL RECORD; PRIORITY JOURNAL; PRIVACY; SHORT SURVEY; STANDARDIZATION;

BIOMEDICAL RESEARCH; CONFIDENTIALITY; EXPERT TESTIMONY; HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT; HUMANS; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 0043281506     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000085720.65685.90     Document Type: Short Survey

References (20)

1. DeMets DL, Califf RM. Lessons learned from recent cardiovascular clinical trials: part I. Circulation. 2002;106:746-751; 880-886.
2. DeMets DL, Califf RM. Lessons learned from recent cardiovascular clinical trials: part II. Circulation. 2002;106:880-886.
3. Califf RM, DeMets DL. Principles from clinical trials relevant to clinical practice: part I. Circulation. 2002;106:1015-1021.
4. Califf RM, DeMets DL. Principles from clinical trials relevant to clinical practice: part II. Circulation. 2002;106:1172-1175.
5. Granger CB. Genetics of coronary heart disease: current understanding and future prospects. Am Heart J. 2000;140:S1-S2.
6. Stead EA Jr. The way of the future. Trans Assoc Am Physicians. 1972; 85:1-5.
7. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err Is Human: Building a Safer Health System. Washington, DC: Institute of Medicine/National Academy Press; 2000.
8. Committee on Quality of Health Care in America. Crossing the Quality Chasm: a New Health System for the 21st Century. Washington, DC: Institute of Medicine/National Academy Press; 2001.
9. Califf RM, Peterson ED, Gibbons RJ, et al. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol. 2002;40:1895-1901.
10. Muhlbaier LH. HIPAA in Clinical Trials: A Practical Guide for Research Compliance. Marblehead, Mass: HCPro, Inc; 2002.
11. Sung N, Crowley WF Jr, Gemel M, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003;289:1278-1287.
12. Eisenstein EL, Lemons PW II, Tardiff BE, et al. Reducing the costs of phase III cardiovascular clinical trials. Am Heart J. 2003. In press.
13. US Department of Health and Human Services. Federal government announces first federal e-gov health information exchange standards. Available at http://www.hhs.gov/news/press/2003pres/20030321a.html. Accessed March 27, 2003.
14. DeAngelis CD. NIH director Elias A. Zerhouni, MD, reflects on agency's challenges, priorities. JAMA. 2003;289:1492-1493.
15. Buckovich SA, Rippen HE, Rozen MJ. Driving toward guiding principles: a goal for privacy, confidentiality, and security of health information. JAMA. 1999;6:122-133.
16. Annas GJ. HIPAA regulations - a new era of medical-record privacy? N Engl J Med. 2003;348:1486-1490.
17. Kilbridge P. The cost of HIPAA compliance. N Engl J Med. 2003;348:1423-1424.
18. Morse MA, Califf RM, Sugarman J. Monitoring and ensuring safety during clinical research. JAMA. 2001;285:1201-1205.
19. Califf RM, Morse MA, Wittes J, et al. Towards protecting the safety of participants in clinical trials. Contr Clin Trials. 2003;24:256-271.
20. The CERTs Risk Assessment Workshop Participants. Risk assessment of drugs, biologics and therapeutic devices: current approaches and future directions. Pharmacoepidemiol Drug Saf. 2003. In press.